ArticleThe oncologist2023

Real-World Evaluation of Disease Progression After CDK 4/6 Inhibitor Therapy in Patients With Hormone Receptor-Positive Metastatic Breast Cancer.

Malinda T West et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.